CHA
ABBV icon

Cedar Hill Associates’s AbbVie ABBV Stock Holding History

Cedar Hill Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-14,018
Closed -$1.32M – 109
2018
Q3 		$1.32M Sell
14,018
-4,570
-25% -$433K 0.3% 60
2018
Q2 		$1.72M Buy
18,588
+196
+1% +$19.1K 0.36% 57
2018
Q1 		$1.74M Sell
18,392
-42
-0.2% -$4.61K 0.35% 58
2017
Q4 		$1.78M Buy
18,434
+953
+5% +$89.8K 0.31% 62
2017
Q3 		$1.55M Buy
17,481
+4,608
+36% +$351K 0.27% 64
2017
Q2 		$933K Hold
12,873
– – 0.19% 61
2017
Q1 		$839K Sell
12,873
-274
-2% -$17.2K 0.17% 58
2016
Q4 		$823K Hold
13,147
– – 0.14% 55
2016
Q3 		$829K Hold
13,147
– – 0.14% 56
2016
Q2 		$814K Hold
13,147
– – 0.14% 58
2016
Q1 		$751K Hold
13,147
– – 0.13% 59
2015
Q4 		$779K Hold
13,147
– – 0.14% 59
2015
Q3 		$715K Buy
13,147
+100
+0.8% +$6.51K 0.13% 58
2015
Q2 		$877K Sell
13,047
-200
-2% -$13.1K 0.14% 61
2015
Q1 		$775K Sell
13,247
-820
-6% -$49.5K 0.12% 62
2014
Q4 		$921K Buy
14,067
+5,200
+59% +$328K 0.15% 64
2014
Q3 		$512K Buy
8,867
+174
+2% +$9.66K 0.08% 69
2014
Q2 		$491K Buy
8,693
+360
+4% +$18.9K 0.08% 67
2014
Q1 		$428K Sell
8,333
-650
-7% -$32.9K 0.07% 67
2013
Q4 		$474K Hold
8,983
– – 0.08% 66
2013
Q3 		$402K Sell
8,983
-110
-1% -$4.88K 0.08% 66
2013
Q2 		$376K Buy
+9,093
New +$398K 0.07% 69

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cedar Hill Associates's ABBV Position: Q4 2018 in Review

Cedar Hill Associates sold out of AbbVie (ABBV) in Q4 2018, closing a stake of 14,018 shares — an estimated $1.32M sold.

Cedar Hill Associates first reported a position in ABBV in Q2 2013 and held it in 22 quarters. The position peaked at $1.78M in Q4 2017. 2,062 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

  • Cedar Hill Associates reported no remaining AbbVie position as of Q4 2018 after selling out during the quarter.
  • Cedar Hill Associates sold 14,018 AbbVie shares in Q4 2018, an estimated $1.32M.
  • Cedar Hill Associates first reported a position in AbbVie in Q2 2013 and held it in 22 quarters.
  • Cedar Hill Associates's AbbVie position peaked at $1.78M in Q4 2017.
  • 2,062 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on Cedar Hill Associates's 13F filing for Q4 2018, filed 13 Feb 2019.